GenSight Biologics S.A. (GSGTF)
OTCMKTS
· Delayed Price · Currency is USD
0.2400
-0.0800 (-25.00%)
At close: Dec 31, 2024
GenSight Biologics Employees
GenSight Biologics had 16 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
16
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$169,855
Profits / Employee
-$905,956
Market Cap
39.14M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
SS Innovations International | 378 |
Endo Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Northwest Biotherapeutics | 25 |
Glass House Brands | 374 |
CytoDyn | 9 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
GenSight Biologics News
- 17 days ago - GenSight Biologics Announces the Filing of its 2024 Universal Registration Document - Business Wire
- 17 days ago - GenSight Biologics Reports Cash Position as of March 31, 2025, and Provides Business Update - Business Wire
- 5 weeks ago - GenSight Biologics Confirms Definitive Full-Year 2024 Consolidated Financial Results Are in Line with Estimates - Business Wire
- 5 weeks ago - GenSight Biologics Announces LUMEVOQ® Scientific Updates at NANOS 2025 - Business Wire
- 7 weeks ago - GenSight Biologics S.A. reports FY results - Seeking Alpha
- 2 months ago - GenSight Biologics Reports Estimated Full-Year 2024 Consolidated Financial Results - Business Wire
- 2 months ago - GenSight Biologics Announces Five-Year Efficacy and Safety Results for LUMEVOQ® Gene Therapy at the Conclusion of the REFLECT Study - Business Wire
- 3 months ago - GenSight Biologics Reports End-of-Year Cash Position and Provides Business Update - Business Wire